Free Trial

International Biotechnology (LON:IBT) Stock Passes Above 200 Day Moving Average - Should You Sell?

International Biotechnology logo with Financial Services background

International Biotechnology (LON:IBT - Get Free Report)'s share price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 669.83 ($8.48) and traded as high as GBX 676 ($8.55). International Biotechnology shares last traded at GBX 670 ($8.48), with a volume of 54,729 shares.

International Biotechnology Trading Up 0.6 %

The stock has a fifty day moving average of GBX 685.95 and a 200 day moving average of GBX 670.22. The company has a market capitalization of £249.11 million, a P/E ratio of 1,404.17 and a beta of 0.21. The company has a debt-to-equity ratio of 9.66, a quick ratio of 0.32 and a current ratio of 0.46.

About International Biotechnology

(Get Free Report)

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.

Read More

Should you invest $1,000 in International Biotechnology right now?

Before you consider International Biotechnology, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and International Biotechnology wasn't on the list.

While International Biotechnology currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines